Clinion eClinical Platform

Clinion eClinical Platform is a global clinical technology company located in the United States. As a privately held entity, Clinion employs 36 people and generates approximately $50 million in annual revenue. The company focuses on developing and providing innovative eClinical solutions for the pharmaceutical and biotechnology industries. Clinion specializes in AI-enabled software applications designed to streamline and optimize the entire clinical trial lifecycle. Their comprehensive suite of products includes Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM/IWRS), Clinical Trial Management System (CTMS), eConsent & Outcome Assessments (eCOA), and Document Automation. These solutions are tailored to meet the diverse needs of clinical trial sponsors, contract research organizations (CROs), and research sites. Clinion differentiates itself through its commitment to leveraging artificial intelligence (AI) and machine learning (ML) to enhance the efficiency and effectiveness of clinical trials. Their AI-powered solutions aim to reduce costs, accelerate timelines, and improve data quality, ultimately empowering their partners to bring life-saving therapies to market faster. Clinion can be reached through their website at clinion.com, or on social media platforms such as Facebook, Twitter, YouTube, and Instagram.